Page last updated: 2024-11-07

3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate: a surfactant; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107670
CHEMBL ID450950
CHEBI ID1418
SCHEMBL ID116864
MeSH IDM0091032

Synonyms (38)

Synonym
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate
chaps ,
3-[(3-cholamidopropyl)dimethylammonium]-1-propansulfonate
3-[(3-cholamidopropyl)-dimethylammonio]-1-propane-sulfonate
chebi:1418 ,
CHEMBL450950
3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azaniumyl]propane-1-sulfonate
c32h58n2o7s
HY-15435
qbp25342ag ,
1-propanaminium, n,n-dimethyl-n-(3-sulfopropyl)-3-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-, hydroxide, inner salt
cholic acid sulfobetaine1-propanaminium, n,n-dimethyl-3-sulfo-n-(3-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)propyl)-, hydroxide, inner salt
unii-qbp25342ag
1-propanaminium, n,n-dimethyl-3-sulfo-n-(3-(((3alpha,5beta,7alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)propyl)-,hydroxide, inner salt
3-((3-cholamidopropyl)dimethylammonio)-1-propanesulfonate
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate
CS-0926
SCHEMBL116864
3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]ammonio]propane-1-sulfonate
3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate
3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate
1-propanaminium, n,n-dimethyl-n-(3-sulfopropyl)-3-(((3.alpha.,5.beta.,7.alpha.,12.alpha.)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-, inner salt
chaps [mi]
3-((3-cholamidopropyl)dimethylammonio)-1-propanesulphonate
AKOS027399767
3-(dimethyl(3-((r)-4-((3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanamido)propyl)ammonio)propane-1-sulfonate
J-018379
3-(3-cholamidopropyl)dimethylammonio-1-propanesulfonate
3-[dimethyl(3-{[(3beta,5alpha,7alpha,12alpha,14beta,17alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl]amino}propyl)ammonio]propane-1-sulfonate
DS-14351
3-(dimethyl{3-[(3,7,12,24-tetrahydroxycholan-24-ylidene)amino]propyl}azaniumyl)propane-1-sulfonate
DTXSID70997059
Q2423649
1-propanaminium,n,n-dimethyl-n-(3-sulfopropyl)-3-[[(3a,5b,7a,12a)-3,7,12-trihydroxy-24-oxocholan-24-yl]amino]-, inner salt
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulphonate
A865651
HB5072

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" Usually, the urea/thiourea based standard protein extraction buffer (SB) is combined with detergents with the aim of achieving better resolution and solubilization of different classes of proteins."( The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis.
Camillo Novello, J; Crepaldi Domingues, C; de Paula, E; Dias-Neto, E; dos Santos Farias, A; Gattaz, WF; Horiuchi, RS; Marangoni, S; Martins, D; Martins-de-Souza, D; Menezes de Oliveira, B, 2007
)
0.34

Dosage Studied

ExcerptRelevanceReference
" The 5-MD activity was recovered in a dose-response manner with all phospholipids studied, but PS was the most effective agent for reconstitution."( Evidence that the human placental 5-monodeiodinase is a phospholipid-requiring enzyme.
Chopra, IJ; Chua Teco, GN; Santini, F; Solomon, DH, 1992
)
0.28
" A full dose-response relationship could not be constructed for proendothelin, but the highest dose used (4 nmol) increased the perfusion pressure by 15."( Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat.
Douglas, SA; Hiley, CR, 1990
)
0.28
" There was a dose-response relationship between the amount of drug administered to the rats and 14C labeling of the membrane pool of factor X carboxylase substrates."( Early processing of prothrombin and factor X by the vitamin K-dependent carboxylase.
Martin, LF; Wallin, R, 1988
)
0.27
" To this end, dose-response curves to phenylephrine and BaCl2 were studied in the renal vasculature under basal conditions and after the infusion of N(omega)-nitro-L-arginine methyl ester (L-NAME) and tetraethylammonium (TEA) in endothelium-intact and endothelium-denuded (CHAPS-treated) preparations."( Modulatory role of endothelium-derived relaxing factors on the response to vasoconstrictors and flow-pressure curve in the isolated perfused rat kidney.
Osuna, A; Vargas, F,
)
0.13
" Indomethacin did not alter the dose-response curves to KCl or Phe in either swimming or control groups."( Effects of exercise training on responsiveness of the mesenteric arterial bed to phenylephrine and KCl in male rats.
Hirunpan, P; Jansakul, C, 1999
)
0.3
"The efficacy of on-demand HIV pre-exposure prophylaxis (PrEP) for men in sub-Saharan Africa has not been evaluated, and the on-demand PrEP dosing requirement for insertive sex remains unknown."( Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.
Alieu, A; Alinde, B; Callebaut, C; Chiodi, F; Else, L; Fox, J; Gray, CM; Herrera, C; Kaleebu, P; Khoo, S; Limakatso, L; Martinson, N; Mugaba, S; Muhumuza, R; Namubiru, P; O'Hagan, K; Odoch, G; Opoka, D; Penchala, SD; Petkov, S; Pillay, AD; Seatlholo, P; Seeley, J; Seiphetlo, TB; Serwanga, J; Ssemata, AS; Webb, EL; Weiss, H, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
1,1-diunsubstituted alkanesulfonateAn alkanesulfonate in which the carbon at position 1 is attached to at least two hydrogens.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
enterobacterial common antigen biosynthesis1133
superpathway of chorismate metabolism56186
ubiquinol-8 biosynthesis (prokaryotic)830
superpathway of ubiquinol-8 biosynthesis (prokaryotic)1141

Bioassays (2)

Assay IDTitleYearJournalArticle
AID351149Increase in West Nile virus NS3 protease activity up to 0.5% by spectrofluorimetry using Boc-Gly-Lys-Arg-AMC substrate relative to control2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Effects of detergents on the West Nile virus protease activity.
AID351148Increase in West Nile virus NS3 protease activity at =>0.01 to 0.1 % by spectrofluorimetry using Boc-Gly-Lys-Arg-AMC substrate relative to control2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Effects of detergents on the West Nile virus protease activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (755)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990196 (25.96)18.7374
1990's327 (43.31)18.2507
2000's163 (21.59)29.6817
2010's64 (8.48)24.3611
2020's5 (0.66)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.26%)5.53%
Reviews3 (0.39%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other769 (99.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]